In Biotech ‘Cash Is King’ When Wall Street Searches for Value

(Bloomberg) -- For investors looking for deals in biotech, Wall Street firms like Baird advise “cash is king.”
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.